FDA Inspection
Divi's Laboratories Ltd. (Unit II)Divi's Laboratories Ltd. (Unit II) – FDA Inspection, Sep 19, 2017
Record Details
This FDA Inspection record concerns Divi's Laboratories Ltd. (Unit II), with an inspection on September 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Erika V. Butler (FDA Associated Person)
- Tsedenia Woldehanna (Issuing Officer)
View Company Profile
ID · 8de2af83-6a2e-41db-85f2-4ba57b235649
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1029997
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Divi's Laboratories Ltd. (Unit II)
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2019 | Not classified | Office of Inspections and Investigations | |
| December 6, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Divi's Laboratories Ltd. (Unit II)
- FDA Inspection 1244994 - 2024-07-19
- FDA Inspection 1121124 - 2020-01-31
- FDA Inspection 1098033 - 2019-06-15
- FDA Inspection 996506 - 2016-12-06
- FDA Inspection 960638 - 2016-02-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.